THUMPD2
gene geneOn this page
Also known as MGC2454
Summary
THUMPD2 (THUMP domain 2 tRNA and snRNA guanosine methyltransferase, HGNC:14890) is a protein-coding gene on chromosome 2p22.1, encoding U6 snRNA (guanine-N(2))-methyltransferase THUMPD2 (Q9BTF0). Catalytic subunit of the THUMPD2-TRM112 methyltransferase complex, that specifically mediates the S-adenosyl-L-methionine-dependent N(2)-methylation of guanosine nucleotides, most probably at position 72 (m2G72), in the U6snRNA of the major spliceosome.
Enables snRNA methyltransferase activity. Involved in regulation of alternative mRNA splicing, via spliceosome. Part of tRNA methyltransferase complex. Is active in nucleus.
Source: NCBI Gene 80745 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 114 total
- MANE Select transcript:
NM_025264
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14890 |
| Approved symbol | THUMPD2 |
| Name | THUMP domain 2 tRNA and snRNA guanosine methyltransferase |
| Location | 2p22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC2454 |
| Ensembl gene | ENSG00000138050 |
| Ensembl biotype | protein_coding |
| OMIM | 611751 |
| Entrez | 80745 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 9 protein_coding, 3 protein_coding_CDS_not_defined, 3 retained_intron, 2 nonsense_mediated_decay
ENST00000378727, ENST00000403537, ENST00000460072, ENST00000505747, ENST00000510781, ENST00000527689, ENST00000530095, ENST00000530522, ENST00000531687, ENST00000933808, ENST00000933809, ENST00000933810, ENST00000933811, ENST00000933812, ENST00000933813, ENST00000933814, ENST00000953485
RefSeq mRNA: 11 — MANE Select: NM_025264
NM_001321468, NM_001321469, NM_001321470, NM_001321474, NM_001321475, NM_001321477, NM_001321478, NM_001321479, NM_001321480, NM_001321481, NM_025264
CCDS: CCDS1805
Canonical transcript exons
ENST00000505747 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001620073 | 39736061 | 39737059 |
| ENSE00003467368 | 39769710 | 39770119 |
| ENSE00003472914 | 39744370 | 39744478 |
| ENSE00003528582 | 39761331 | 39761418 |
| ENSE00003547695 | 39771505 | 39771640 |
| ENSE00003596318 | 39768424 | 39768501 |
| ENSE00003605092 | 39766057 | 39766109 |
| ENSE00003629577 | 39755889 | 39755960 |
| ENSE00003655678 | 39755295 | 39755409 |
| ENSE00003841951 | 39779114 | 39779258 |
Expression profiles
Bgee: expression breadth ubiquitous, 232 present calls, max score 91.17.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 13.6218 / max 247.5100, expressed in 1768 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 27935 | 13.3269 | 1764 |
| 27934 | 0.2949 | 137 |
Top tissues by expression
264 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ascending aorta | UBERON:0001496 | 91.17 | gold quality |
| thoracic aorta | UBERON:0001515 | 91.09 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 91.07 | gold quality |
| calcaneal tendon | UBERON:0003701 | 90.44 | gold quality |
| right coronary artery | UBERON:0001625 | 89.89 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 89.49 | gold quality |
| cerebellar cortex | UBERON:0002129 | 89.33 | gold quality |
| left ovary | UBERON:0002119 | 88.99 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 88.99 | gold quality |
| aorta | UBERON:0000947 | 88.96 | gold quality |
| right ovary | UBERON:0002118 | 87.57 | gold quality |
| popliteal artery | UBERON:0002250 | 87.53 | gold quality |
| tibial artery | UBERON:0007610 | 87.52 | gold quality |
| cerebellum | UBERON:0002037 | 87.39 | gold quality |
| mucosa of stomach | UBERON:0001199 | 86.91 | gold quality |
| ventricular zone | UBERON:0003053 | 86.91 | gold quality |
| skin of abdomen | UBERON:0001416 | 86.59 | gold quality |
| left coronary artery | UBERON:0001626 | 86.48 | gold quality |
| body of uterus | UBERON:0009853 | 86.23 | gold quality |
| skin of leg | UBERON:0001511 | 85.95 | gold quality |
| ovary | UBERON:0000992 | 85.87 | gold quality |
| endocervix | UBERON:0000458 | 85.58 | gold quality |
| coronary artery | UBERON:0001621 | 85.48 | gold quality |
| tibial nerve | UBERON:0001323 | 85.46 | gold quality |
| minor salivary gland | UBERON:0001830 | 85.24 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 84.80 | gold quality |
| adenohypophysis | UBERON:0002196 | 84.78 | gold quality |
| ectocervix | UBERON:0012249 | 84.76 | gold quality |
| adrenal tissue | UBERON:0018303 | 84.71 | gold quality |
| body of pancreas | UBERON:0001150 | 84.57 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.07 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
45 targeting THUMPD2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-7978 | 99.86 | 66.90 | 856 |
| HSA-MIR-2052 | 99.79 | 69.37 | 2031 |
| HSA-MIR-1208 | 99.70 | 68.28 | 1533 |
| HSA-MIR-3660 | 99.68 | 67.33 | 1149 |
| HSA-MIR-4526 | 99.68 | 67.07 | 1136 |
| HSA-MIR-466 | 99.67 | 70.85 | 2863 |
| HSA-MIR-892C-3P | 99.65 | 69.38 | 1745 |
| HSA-MIR-452-5P | 99.65 | 69.63 | 1762 |
| HSA-MIR-4676-3P | 99.65 | 69.31 | 1733 |
| HSA-MIR-4516 | 99.61 | 67.78 | 3390 |
| HSA-MIR-1275 | 99.47 | 67.90 | 2749 |
| HSA-MIR-372-5P | 99.41 | 69.11 | 2299 |
| HSA-MIR-889-3P | 99.40 | 69.76 | 2103 |
| HSA-MIR-4279 | 99.19 | 66.70 | 2437 |
| HSA-MIR-6071 | 99.16 | 67.77 | 1780 |
| HSA-MIR-4434 | 99.10 | 67.01 | 1984 |
| HSA-MIR-5703 | 99.10 | 67.09 | 2053 |
| HSA-MIR-371A-5P | 99.08 | 66.51 | 1914 |
| HSA-MIR-7151-3P | 99.04 | 69.72 | 2370 |
Literature-anchored findings (GeneRIF, showing 1)
- THUMPD2 catalyzes the N2-methylation of U6 snRNA of the spliceosome catalytic center and regulates pre-mRNA splicing and retinal degeneration. (PMID:38165050)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | thumpd2 | ENSDARG00000093070 |
| mus_musculus | Thumpd2 | ENSMUSG00000024246 |
| rattus_norvegicus | Thumpd2 | ENSRNOG00000008291 |
| caenorhabditis_elegans | WBGENE00010846 |
Paralogs (1): THUMPD3 (ENSG00000134077)
Protein
Protein identifiers
U6 snRNA (guanine-N(2))-methyltransferase THUMPD2 — Q9BTF0 (reviewed: Q9BTF0)
Alternative names: THUMP domain-containing protein 2
All UniProt accessions (2): Q9BTF0, H0YE26
UniProt curated annotations — full annotation on UniProt →
Function. Catalytic subunit of the THUMPD2-TRM112 methyltransferase complex, that specifically mediates the S-adenosyl-L-methionine-dependent N(2)-methylation of guanosine nucleotides, most probably at position 72 (m2G72), in the U6snRNA of the major spliceosome. This modification in the U6 snRNA affects the constitutive splicing efficiency of introns that have suboptimal splice sites and can impact final mRNA levels.
Subunit / interactions. Part of the heterodimeric THUMPD2-TRM112 methyltransferase complex; this complex forms an active tRNA methyltransferase, where TRMT112 acts as an activator of the catalytic subunit THUMPD2.
Subcellular location. Nucleus.
Tissue specificity. Expressed in a variety of tissues including brain, colon, gingiva, heart, kidney, liver, lung, placenta, small intestine, spleen and thymus.
Similarity. Belongs to the methyltransferase superfamily.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9BTF0-1 | 1 | yes |
| Q9BTF0-2 | 2 |
RefSeq proteins (11): NP_001308397, NP_001308398, NP_001308399, NP_001308403, NP_001308404, NP_001308406, NP_001308407, NP_001308408, NP_001308409, NP_001308410, NP_079540* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000241 | RlmKL-like_Mtase | Domain |
| IPR004114 | THUMP_dom | Domain |
| IPR029063 | SAM-dependent_MTases_sf | Homologous_superfamily |
Pfam: PF01170, PF02926
Catalyzed reactions (Rhea), 1 shown:
- guanosine in U6 snRNA + S-adenosyl-L-methionine = N(2)-methylguanosine in U6 snRNA + S-adenosyl-L-homocysteine + H(+) (RHEA:83423)
UniProt features (4 total): splice variant 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BTF0-F1 | 74.60 | 0.55 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 131 (showing top):
GOBP_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME, GOBP_TRNA_METABOLIC_PROCESS, GOBP_RNA_METHYLATION, WEI_MYCN_TARGETS_WITH_E_BOX, ONKEN_UVEAL_MELANOMA_UP, GOBP_RNA_MODIFICATION, USF_01, GOBP_RNA_SPLICING, GOBP_TRNA_METHYLATION, DODD_NASOPHARYNGEAL_CARCINOMA_UP, GOBP_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME, USF_02, GOBP_METHYLATION, GOBP_TRNA_PROCESSING, GOBP_REGULATION_OF_RNA_SPLICING
GO Biological Process (4): regulation of alternative mRNA splicing, via spliceosome (GO:0000381), tRNA methylation (GO:0030488), RNA processing (GO:0006396), methylation (GO:0032259)
GO Molecular Function (6): RNA binding (GO:0003723), tRNA (guanine) methyltransferase activity (GO:0016423), U6 snRNA (guanine-N(2))-methyltransferase activity (GO:0160230), protein binding (GO:0005515), methyltransferase activity (GO:0008168), transferase activity (GO:0016740)
GO Cellular Component (2): nucleus (GO:0005634), tRNA methyltransferase complex (GO:0043527)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| alternative mRNA splicing, via spliceosome | 1 |
| regulation of mRNA splicing, via spliceosome | 1 |
| RNA methylation | 1 |
| tRNA modification | 1 |
| gene expression | 1 |
| RNA biosynthetic process | 1 |
| primary metabolic process | 1 |
| metabolic process | 1 |
| nucleic acid binding | 1 |
| tRNA methyltransferase activity | 1 |
| S-adenosylmethionine-dependent methyltransferase activity | 1 |
| snRNA methyltransferase activity | 1 |
| binding | 1 |
| transferase activity, transferring one-carbon groups | 1 |
| catalytic activity | 1 |
| intracellular membrane-bounded organelle | 1 |
| methyltransferase complex | 1 |
Protein interactions and networks
STRING
868 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| THUMPD2 | SOS1 | Q07889 | 732 |
| THUMPD2 | TRMT11 | Q7Z4G4 | 624 |
| THUMPD2 | TRMT1L | Q7Z2T5 | 539 |
| THUMPD2 | TRMT1 | Q9NXH9 | 538 |
| THUMPD2 | BUD23 | O43709 | 528 |
| THUMPD2 | FYTTD1 | Q96QD9 | 523 |
| THUMPD2 | ZBTB8OS | Q8IWT0 | 496 |
| THUMPD2 | YRDC | Q86U90 | 483 |
| THUMPD2 | TRMT112 | Q9UI30 | 475 |
| THUMPD2 | TRMT10B | Q6PF06 | 452 |
| THUMPD2 | ZBTB37 | Q5TC79 | 449 |
| THUMPD2 | RGS1 | Q08116 | 445 |
| THUMPD2 | PUS10 | Q3MIT2 | 442 |
| THUMPD2 | TRMT2B | Q96GJ1 | 433 |
| THUMPD2 | FAM222B | Q8WU58 | 430 |
IntAct
16 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRMT112 | BUD23 | psi-mi:“MI:0914”(association) | 0.910 |
| THUMPD2 | WFS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| THUMPD2 | TRMT112 | psi-mi:“MI:0915”(physical association) | 0.540 |
| THUMPD2 | TRMT112 | psi-mi:“MI:0403”(colocalization) | 0.540 |
| THUMPD2 | SPDL1 | psi-mi:“MI:0914”(association) | 0.530 |
| THUMPD2 | NOP58 | psi-mi:“MI:0915”(physical association) | 0.400 |
| HNRNPCL2 | THUMPD2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| THUMPD2 | RALY | psi-mi:“MI:0915”(physical association) | 0.400 |
| HSPB2 | THUMPD2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| M | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (19): THUMPD2 (Two-hybrid), SPDL1 (Affinity Capture-MS), LACRT (Affinity Capture-MS), THUMPD2 (Co-fractionation), THUMPD2 (Proximity Label-MS), RALY (Proximity Label-MS), NOP58 (Proximity Label-MS), LACRT (Affinity Capture-MS), SPDL1 (Affinity Capture-MS), THUMPD2 (Co-fractionation), DUS2 (Co-fractionation), SHOC2 (Co-fractionation), THUMPD2 (Cross-Linking-MS (XL-MS)), THUMPD2 (Affinity Capture-MS), THUMPD2 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A1L3L1, A2RT67, A3KPW7, A4IIA7, A8C750, A8C752, D2HNY3, E1BGQ2, E1C3P4, Q08CL8, Q08DZ8, Q0IHB3, Q149N8, Q1RMU2, Q1RMZ1, Q3MJ13, Q3T1H6, Q5F3F2, Q5RED8, Q5VVJ2, Q5ZJ87, Q66J91, Q69Z66, Q6AYF5, Q6DE97, Q6GR37, Q6P1E7, Q6PNC0, Q6YHU6, Q7TPQ3, Q8BKW4, Q8BXK4, Q8IWR0, Q8IYF3, Q8IZE3, Q8K2I9, Q8NA31, Q8NEN0, Q8NFZ0, Q96EW2
Diamond homologs: A0A0D3MJQ5, B2IUM7, B5FE19, E1B8U2, O66128, Q18511, Q2SN12, Q3A209, Q5E5B4, Q6N3Y0, Q72IH5, Q8KZ94, Q8U248, Q9BTF0, Q9CZB3, A5W9K3, B0KJZ2, B1J5U4, O26820, O29011, O94636, P05409, Q03055, Q1I4C5, Q57880, Q58120, Q59047, Q6NS23, Q74CC6, Q87BR3, Q88DK7, Q96RS0, Q97WC7, Q9PAY7, Q9UY84, A0L8B5, P97770, Q2T9W2, Q9BV44, C3MJI5
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| THUMPD2 | “form complex” | “THUMPD2-TRM112 methyltransferase complex” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
114 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 93 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1304 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:39737058:CT:C | acceptor_gain | 1.0000 |
| 2:39744365:CTTA:C | donor_loss | 1.0000 |
| 2:39744366:TTA:T | donor_loss | 1.0000 |
| 2:39744367:TACCT:T | donor_loss | 1.0000 |
| 2:39744368:A:AC | donor_gain | 1.0000 |
| 2:39744368:AC:A | donor_gain | 1.0000 |
| 2:39744369:C:CT | donor_gain | 1.0000 |
| 2:39744369:CC:C | donor_gain | 1.0000 |
| 2:39744369:CCTTT:C | donor_gain | 1.0000 |
| 2:39744477:TT:T | acceptor_gain | 1.0000 |
| 2:39744479:C:CC | acceptor_gain | 1.0000 |
| 2:39755871:CCAAA:C | donor_gain | 1.0000 |
| 2:39755875:A:C | donor_gain | 1.0000 |
| 2:39755887:A:AC | donor_gain | 1.0000 |
| 2:39755888:C:CC | donor_gain | 1.0000 |
| 2:39755888:CTGG:C | donor_gain | 1.0000 |
| 2:39757247:CCCCA:C | donor_gain | 1.0000 |
| 2:39761325:TCTTA:T | donor_loss | 1.0000 |
| 2:39761326:CTTA:C | donor_loss | 1.0000 |
| 2:39761328:TACCT:T | donor_loss | 1.0000 |
| 2:39761329:A:AC | donor_gain | 1.0000 |
| 2:39761330:C:CC | donor_gain | 1.0000 |
| 2:39761330:C:CG | donor_loss | 1.0000 |
| 2:39761415:AACC:A | acceptor_gain | 1.0000 |
| 2:39761416:ACC:A | acceptor_gain | 1.0000 |
| 2:39761417:CC:C | acceptor_gain | 1.0000 |
| 2:39761417:CCC:C | acceptor_gain | 1.0000 |
| 2:39761418:CC:C | acceptor_gain | 1.0000 |
| 2:39761419:C:CC | acceptor_gain | 1.0000 |
| 2:39761419:C:T | acceptor_gain | 1.0000 |
AlphaMissense
3329 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:39768456:A:G | W240R | 0.985 |
| 2:39768456:A:T | W240R | 0.985 |
| 2:39771612:A:G | F52S | 0.985 |
| 2:39769761:G:C | F207L | 0.983 |
| 2:39769761:G:T | F207L | 0.983 |
| 2:39769763:A:G | F207L | 0.983 |
| 2:39779182:A:G | C20R | 0.983 |
| 2:39771618:A:T | V50D | 0.982 |
| 2:39779180:G:C | C20W | 0.982 |
| 2:39744426:A:C | F377L | 0.981 |
| 2:39744426:A:T | F377L | 0.981 |
| 2:39744428:A:G | F377L | 0.981 |
| 2:39755947:A:T | V302D | 0.981 |
| 2:39766073:C:A | G263W | 0.981 |
| 2:39771554:A:C | F71L | 0.980 |
| 2:39771554:A:T | F71L | 0.980 |
| 2:39771556:A:G | F71L | 0.980 |
| 2:39761400:T:A | R274S | 0.976 |
| 2:39761400:T:G | R274S | 0.976 |
| 2:39769747:C:G | R212P | 0.976 |
| 2:39766072:C:T | G263E | 0.975 |
| 2:39771611:G:C | F52L | 0.975 |
| 2:39771611:G:T | F52L | 0.975 |
| 2:39771613:A:G | F52L | 0.975 |
| 2:39766073:C:G | G263R | 0.974 |
| 2:39766073:C:T | G263R | 0.974 |
| 2:39769758:T:A | R208S | 0.974 |
| 2:39769758:T:G | R208S | 0.974 |
| 2:39769762:A:G | F207S | 0.974 |
| 2:39770069:A:G | W105R | 0.974 |
dbSNP variants (sampled 300 via entrez): RS1000007173 (2:39755167 G>A), RS1000011613 (2:39778648 C>A,T), RS1000116185 (2:39773738 T>C,G), RS1000126630 (2:39741522 A>C), RS1000134730 (2:39761155 T>C), RS1000232819 (2:39773464 T>G), RS1000269107 (2:39735704 T>C), RS1000270632 (2:39777491 T>A), RS1000308504 (2:39740444 C>T), RS1000371292 (2:39747303 G>A,T), RS1000476975 (2:39771873 G>A), RS1000526458 (2:39778255 T>A,C), RS1000585010 (2:39756572 G>A), RS1000635643 (2:39751001 T>C), RS1000680154 (2:39740171 CAT>C)
Disease associations
OMIM: gene MIM:611751 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000273_3 | Personality dimensions | 3.000000e-06 |
| GCST008178_2 | Early spontaneous preterm birth | 3.000000e-06 |
| GCST009391_1736 | Metabolite levels | 1.000000e-06 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004365 | personality trait |
| EFO:0006917 | spontaneous preterm birth |
| EFO:0010376 | phosphatidylcholine 34:2 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| sodium arsenite | decreases expression | 1 |
| cylindrospermopsin | increases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| Leflunomide | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.